Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Control Bionics Ltd. ( (AU:CBL) ) has issued an announcement.
Control Bionics Limited has announced the quotation of 32,874,567 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 17, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial standing and visibility in the market, potentially benefiting stakeholders by increasing the liquidity and marketability of its shares.
More about Control Bionics Ltd.
Control Bionics Limited operates in the technology industry, focusing on developing and providing advanced communication and control solutions for individuals with disabilities. The company is known for its innovative products that enhance the quality of life for people with severe physical impairments, enabling them to communicate and interact with the world more effectively.
Average Trading Volume: 137,709
Technical Sentiment Signal: Sell
Current Market Cap: A$12.02M
For detailed information about CBL stock, go to TipRanks’ Stock Analysis page.